SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 18792.
  • 2
    Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985; 1: 4259.
  • 3
    Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983; 98: 7685.
  • 4
    Koukoura O, Mantas N, Linardakis H, Hajiioannou J, Sifakis S. Successful term pregnancy in a patient with Wegener's granulomatosis: case report and literature review. Fertil Steril 2008; 89: 457.e1–5.
  • 5
    Pagnoux C, Le Guern V, Goffinet F, Diot E, Limal N, Pannier E, et al. Pregnancies in systemic necrotizing vasculitides: report on 12 women and their 20 pregnancies. Rheumatology (Oxford) 2011; 50: 95361.
  • 6
    Alfhaily F, Watts R, Leather A. Wegener's granulomatosis occurring de novo during pregnancy. Clin Exp Rheumatol 2009; 27: S868.
  • 7
    Kim SY, Linton JM, Kolasinski SL. Successful treatment of new onset Wegener's granulomatosis with IVIG (intravenous immunoglobulin) during pregnancy: a case report. Mod Rheumatol 2008; 18: 17780.
  • 8
    Scholz A, Srinivas K, Stacey MR, Clyburn P. Subglottic stenosis in pregnancy. Br J Anaesth 2008; 100: 3858.
  • 9
    Dhir S, Fuller J. Case report: pregnancy in hemodialysis-dependent end-stage renal disease: anesthetic considerations. Can J Anaesth 2007; 54: 55660.
  • 10
    Zuppa AA, De Luca D, Cota F, De Carolis S, Savone R, Manna R. Mild and transient neutropenia in an infant of mother with Wegener's granulomatosis. Minerva Pediatr 2006; 58: 57981.
  • 11
    Silva F, Specks U, Sethi S, Irazabal MV, Fervenza FC. Successful pregnancy and delivery of a healthy newborn despite transplacental transfer of antimyeloperoxidase antibodies from a mother with microscopic polyangiitis. Am J Kidney Dis 2009; 54: 5425.
  • 12
    Bansal PJ, Tobin MC. Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 2004; 93: 398401.
  • 13
    Milne KL, Stanley KP, Temple RC, Barker TH, Ross CN. Microscopic polyangiitis: first report of a case with onset during pregnancy. Nephrol Dial Transplant 2004; 19: 2347.
  • 14
    Cetinkaya R, Odabas AR, Gursan N, Selcuk Y, Erdogan F, Keles M, et al. Microscopic polyangiitis in a pregnant woman. South Med J 2002; 95: 14413.
  • 15
    Morton MR. Hypersensitivity vasculitis (microscopic polyangiitis) in pregnancy with transmission to the neonate. Br J Obstet Gynaecol 1998; 105: 92830.
  • 16
    Biesenbach G, Stoger H, Zazgornik J. Successful pregnancy of twins in a renal transplant patient with Wegener's granulomatosis. Nephrol Dial Transplant 1991; 6: 13940.
  • 17
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 3141.
  • 18
    Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 6718.
  • 19
    Exley AR, Bacon PA, Luqmani RA, Kitas GD, Gordon C, Savage CO, et al. Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 1997; 40: 37180.
  • 20
    Visser GH, Eilers PH, Elferink-Stinkens PM, Merkus HM, Wit JM. New Dutch reference curves for birthweight by gestational age. Early Hum Dev 2009; 85: 73744.
  • 21
    Min SJ, Luke B, Gillespie B, Min L, Newman RB, Mauldin JG, et al. Birth weight references for twins. Am J Obstet Gynecol 2000; 182: 12507.
  • 22
    ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77: 6775.
  • 23
    Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IXXIV.
  • 24
    Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A 2009; 149A: 12418.
  • 25
    American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics, Society for Maternal-Fetal Medicine, ACOG Joint Editorial Committee. ACOG Practice Bulletin #56: multiple gestation: complicated twin, triplet, and high-order multifetal pregnancy. Obstet Gynecol 2004; 104: 86983.
  • 26
    Yang J, Xie RH, Krewski D, Wang YJ, Walker M, Wen SW. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight. Int J Infect Dis 2011; 15: e33641.
  • 27
    Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm infants. Pediatrics 2005; 116: e8338.
  • 28
    Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010; 363: 22132.